Sign in to view content

National Cohort Study on New Oral Hypoglycemic Agents in Diabetic Retinopathy Progression

Ehsan Rahimy, MD

Video
Published 2023

Related

Open-Label Study Evaluating the Effects of the CCR3 Antagonist ALK4290 in Patients With Neovascular AMD Refractory to Anti-VEGF Therapy
Michael W. Stewart, MD
Annual Meeting Talks
2019
Brolucizumab: Will it Make a Differance
Andrew P. Schachat, MD
Updates from the Field
2018
Intermittent to Continuous Therapy for Diabetic Macular Edema leads to Reduction in Treatment Frequency and Reduced Retinal Thickness Fluctuations
Seenu M. Hariprasad, MD
On Demand Cases, Courses, and Papers
2019

Category: Diabetic Retinopathy

See more